Silencing PRL-3 in colon cancer cells has been shown to lead to a ROS-dependent DNA damage response and senescence, indicating a potential link between PRL-3 and acquired resistance [121]. The gene discussed is PTP4A3; the disease is malignant colon neoplasm.